Literature DB >> 33817216

MiR-489-3p inhibits cell proliferation, migration, and invasion, and induces apoptosis, by targeting the BDNF-mediated PI3K/AKT pathway in glioblastoma.

Bo Zheng1, Tao Chen1.   

Abstract

Among astrocyte tumors, glioblastoma (GBM) is the most malignant glioma, highly aggressive and invasive, with extremely poor prognosis. Previous research has reported that microRNAs (miRNAs) participate in the progression of many cancers. Thus, this study aimed to explore the role and the underlying mechanisms of microRNA (miR)-489-3p in GBM progression. The expression of miR-489-3p and brain-derived neurotrophic factor (BDNF) mRNA was measured by quantitative real-time polymerase chain reaction. Western blot analysis was used to detect BDNF protein and the PI3K/AKT pathway-related protein. Cell proliferation, apoptosis, migration, and invasion were analyzed using CKK-8 assay, flow cytometry, and transwell assay, respectively. The interaction between BDNF and miR-489-3p was explored by luciferase reporter assay and RNA immunoprecipitation (RIP) assay. MiR-489-3p was down-regulated and BDNF was up-regulated in GBM tissues and cells. MiR-489-3p re-expression or BDNF knockdown inhibited GBM cell proliferation, migration, and invasion, and promoted apoptosis. BDNF was a target of miR-489-3p, and BDNF up-regulation reversed the effects of miR-489-3p on GBM cells. The protein levels of p-AKT and p-PI3K were notably reduced in GBM cells by overexpression of miR-489-3p, but were rescued following BDNF up-regulation. Therefore, miR-489-3p inhibited proliferation, migration, and invasion, and induced apoptosis, by targeting the BDNF-mediated PI3K/AKT pathway in GBM, providing new strategies for clinical treatment of GBM.
© 2020 Bo Zheng and Tao Cheng, published by De Gruyter.

Entities:  

Keywords:  apoptosis; brain-derived neurotrophic factor; glioblastoma; invasion; miR-489-3p; migration

Year:  2020        PMID: 33817216      PMCID: PMC7874546          DOI: 10.1515/biol-2020-0024

Source DB:  PubMed          Journal:  Open Life Sci        ISSN: 2391-5412            Impact factor:   0.938


  31 in total

1.  Brain-derived neurotrophic factor increases vascular endothelial growth factor expression and enhances angiogenesis in human chondrosarcoma cells.

Authors:  Chih-Yang Lin; Shih-Ya Hung; Hsien-Te Chen; Hsi-Kai Tsou; Yi-Chin Fong; Shih-Wei Wang; Chih-Hsin Tang
Journal:  Biochem Pharmacol       Date:  2014-08-19       Impact factor: 5.858

2.  Mature brain-derived neurotrophic factor and its receptor TrkB are upregulated in human glioma tissues.

Authors:  Jing Xiong; L I Zhou; Yoon Lim; Miao Yang; Yu-Hong Zhu; Zhi-Wei Li; Deng-Li Fu; Xin-Fu Zhou
Journal:  Oncol Lett       Date:  2015-05-06       Impact factor: 2.967

3.  Brain-derived neurotrophic factor/tropomyosin-related kinase B signaling pathway contributes to the aggressive behavior of lung squamous cell carcinoma.

Authors:  Keigo Ozono; Yoshihiro Ohishi; Hideya Onishi; Katsuya Nakamura; Junichi Motoshita; Masato Kato; Ryoichi Nakanishi; Masafumi Nakamura; Yoshinao Oda
Journal:  Lab Invest       Date:  2017-06-12       Impact factor: 5.662

4.  Extensive modulation of a set of microRNAs in primary glioblastoma.

Authors:  S A Ciafrè; S Galardi; A Mangiola; M Ferracin; C-G Liu; G Sabatino; M Negrini; G Maira; C M Croce; M G Farace
Journal:  Biochem Biophys Res Commun       Date:  2005-09-09       Impact factor: 3.575

5.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

Authors:  Roger Stupp; Monika E Hegi; Warren P Mason; Martin J van den Bent; Martin J B Taphoorn; Robert C Janzer; Samuel K Ludwin; Anouk Allgeier; Barbara Fisher; Karl Belanger; Peter Hau; Alba A Brandes; Johanna Gijtenbeek; Christine Marosi; Charles J Vecht; Karima Mokhtari; Pieter Wesseling; Salvador Villa; Elizabeth Eisenhauer; Thierry Gorlia; Michael Weller; Denis Lacombe; J Gregory Cairncross; René-Olivier Mirimanoff
Journal:  Lancet Oncol       Date:  2009-03-09       Impact factor: 41.316

6.  The effects of combined treatment with sevoflurane and cisplatin on growth and invasion of human adenocarcinoma cell line A549.

Authors:  Hua Liang; Han Bing Wang; Hong Zhen Liu; Xian Jie Wen; Qiao Ling Zhou; Cheng Xiang Yang
Journal:  Biomed Pharmacother       Date:  2013-03-29       Impact factor: 6.529

7.  Upregulation of the BDNF/TrKB pathway promotes epithelial-mesenchymal transition, as well as the migration and invasion of cervical cancer.

Authors:  Yuan Yuan; Hai-Qiong Ye; Qian-Chuan Ren
Journal:  Int J Oncol       Date:  2017-12-19       Impact factor: 5.650

8.  MicroRNA-107 inhibits tumor growth and metastasis by targeting the BDNF-mediated PI3K/AKT pathway in human non-small lung cancer.

Authors:  Huan Xia; Yang Li; Xiaohong Lv
Journal:  Int J Oncol       Date:  2016-07-25       Impact factor: 5.650

9.  MiR-29b inhibits the growth of glioma via MYCN dependent way.

Authors:  Guan Sun; Jingmin Lu; Chuang Zhang; Ran You; Lei Shi; Nan Jiang; Dekang Nie; Jian Zhu; Min Li; Jun Guo
Journal:  Oncotarget       Date:  2017-07-11

10.  Brain-derived neurotrophic factor/tropomyosin-related kinase B pathway in gastric cancer.

Authors:  Y Okugawa; K Tanaka; Y Inoue; M Kawamura; A Kawamoto; J Hiro; S Saigusa; Y Toiyama; M Ohi; K Uchida; Y Mohri; M Kusunoki
Journal:  Br J Cancer       Date:  2012-11-22       Impact factor: 7.640

View more
  4 in total

Review 1.  BDNF and its signaling in cancer.

Authors:  Mohammad Malekan; Sasan Salehi Nezamabadi; Elham Samami; Mehdi Mohebalizadeh; Amene Saghazadeh; Nima Rezaei
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-29       Impact factor: 4.322

2.  Salvianolic acid A (Sal A) suppresses malignant progression of glioma and enhances temozolomide (TMZ) sensitivity via repressing transgelin-2 (TAGLN2) mediated phosphatidylinositol-3-kinase (PI3K) / protein kinase B (Akt) pathway.

Authors:  Tingting Ye; Rongrong Chen; Yu Zhou; Juan Zhang; Zhongqin Zhang; Hui Wei; Yan Xu; Yulan Wang; Yinlan Zhang
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

3.  Long intergenic non-protein coding RNA 115 (LINC00115) aggravates retinoblastoma progression by targeting microRNA miR-489-3p that downregulates 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 (PFKFB2).

Authors:  Fang Ji; Chunhua Dai; Meng Xin; Jing Zhang; Yuru Zhang; Shu Liu
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

4.  Astragaloside IV exhibits anti-tumor function in gastric cancer via targeting circRNA dihydrolipoamide S-succinyltransferase (circDLST)/miR-489-3p/ eukaryotic translation initiation factor 4A1(EIF4A1) pathway.

Authors:  Fagen Li; Ke Cao; Maoyun Wang; Yi Liu; Yin Zhang
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.